Tuesday Dec 10
Fosamax Settlement Proposed: $27.7M for 1,200 Plaintiffs
In a large Fosamax settlement, pharmaceutical giant Merck & Co. Inc. has agreed to pay $27.7 million to about 1,200 plaintiffs who claimed the osteoporosis drug caused bones in their jaws to deteriorate.
Proton pump inhibitor use and the antifracture efficacy of alendronate.
Archives of internal medicine , Vol. 171, No. 11. , pp. 998-1004, doi:10.1001/archinternmed.2011.20 Proton pump inhibitors are widely used in elderly patients and are frequently coadministered in users of oral bisphosphonates.